Safety and efficacy of extended pyrazinamide (PZA) administration for prolonged smear positive pulmonary tuberculosis
Not Applicable
- Conditions
- pulmonary tuberculosis
- Registration Number
- JPRN-UMIN000012243
- Lead Sponsor
- ational Center for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)HIV positive 2)Systemic corticosteroids or other imunosuppressants administration 3)Pregnancy or breast feeding 4)Resistance of INH and/or RFP 5)Hyperuricemia or past history of gout 6)Any laboratory abnormal finding as follows; T-bil >= 3.0 mg/dL, WBC < 2,000 /mm3, Hgb < 7.0 g/dL, or Plt < 50,000 /mm3 7)Others judjed to be unsuitable as subjects by the physicians in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method